2022-06-01 16:08 | CC:MOOD | Doseology Sciences Inc | 0.075 | News Release200 | Doseology Sciences receives OK for OTC Pink listing |
2022-05-30 21:40 | CC:MOOD | Doseology Sciences Inc | 0.045 | SEDAR MD & A815 | SEDAR MD & A |
2022-05-30 21:02 | CC:MOOD | Doseology Sciences Inc | 0.045 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2022-04-22 16:45 | CC:MOOD | Doseology Sciences Inc | 0.095 | News Release200 | Doseology signs distribution agreement, names Olson CEO |
2022-03-01 18:15 | CC:MOOD | Doseology Sciences Inc | 0.09 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2022-03-01 18:15 | CC:MOOD | Doseology Sciences Inc | 0.09 | SEDAR MD & A815 | SEDAR MD & A |
2022-01-28 10:39 | CC:MOOD | Doseology Sciences Inc | 0.17 | News Release200 | Doseology Sciences appoints Geh as CFO |
2022-01-13 12:17 | CC:MOOD | Doseology Sciences Inc | 0.24 | News Release200 | Doseology Sciences appoints Marissen as CEO, director |
2022-01-06 13:00 | CC:MOOD | Doseology Sciences Inc | 0.18 | News Release200 | Doseology completes soft launch of 7 mushroom products |
2021-12-15 13:42 | CC:MOOD | Doseology Sciences Inc | 0.17 | News Release200 | Doseology hires Wellman-Labadie as researcher |
2021-12-06 13:04 | CC:MOOD | Doseology Sciences Inc | 0.155 | News Release200 | Doseology files to become Health Canada licensed dealer |
2021-11-29 17:08 | CC:MOOD | Doseology Sciences Inc | 0.175 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2021-11-29 17:08 | CC:MOOD | Doseology Sciences Inc | 0.175 | SEDAR MD & A815 | SEDAR MD & A |
2021-11-15 14:18 | CC:MOOD | Doseology Sciences Inc | 0.25 | News Release200 | Doseology Sciences begins trading on CSE |
2021-11-11 15:43 | CC:MOOD | Doseology Sciences Inc | | New Listing5 | Doseology Sciences to trade on CSE |